Both Claudin 3 and Occludin protein levels exhibited large variations within ALS samples, with some showing down-regulation of the two markers (in samples grouped as ALS cohort 1, Fig. S2B), while others were characterized by no changes or even increases (samples grouped as cohort 2, Fig. S2B). This evidence concerns the gene CLDN3 and amyotrophic lateral sclerosis.